Cargando…

MerTK is a novel therapeutic target in gastric cancer

INTRODUCTION: The role of MerTK has not been assessed in gastric cancer (GC). The aim of this study was to identify a subgroup of GC patients with MerTK tumor overexpression, and to evaluate MerTK as a potential therapeutic target in this disease. METHODS: Protein and mRNA expression of MerTK were e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Jun Ho, Jang, Jiryeon, Cho, Jeonghee, Do, In-Gu, Hong, Mineui, Kim, Seung Tae, Kim, Kyoung-Mee, Lee, Sujin, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Kang, Won Ki, Lim, Ho Yeong, Lee, Jeeyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722512/ https://www.ncbi.nlm.nih.gov/pubmed/29228560 http://dx.doi.org/10.18632/oncotarget.3750

Ejemplares similares

MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017)

Harnessing MerTK agonism for targeted therapeutics
por: Kedage, Vivekananda, et al.
Publicado: (2019)

MerTK, a risk factor for NASH fibrosis
por: Wang, Xiaobo, et al.
Publicado: (2020)

MerTK is required for apoptotic cell–induced T cell tolerance
por: Wallet, Mark A., et al.
Publicado: (2008)

The Synthesis and Initial Evaluation of MerTK Targeted PET Agents
por: Wang, Li, et al.
Publicado: (2022)

MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS
por: Healy, Luke M., et al.
Publicado: (2017)

MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
por: Knubel, Kristina H., et al.
Publicado: (2014)

Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development
por: Park, Tae Hyun, et al.
Publicado: (2020)

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2014)

High Glucose Impairs Expression and Activation of MerTK in ARPE-19 Cells
por: Puddu, Alessandra, et al.
Publicado: (2022)

N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth
por: Liu, Yongzhang, et al.
Publicado: (2022)

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
por: Triantafyllou, Evangelos, et al.
Publicado: (2018)

Microglia Inhibition Delays Retinal Degeneration Due to MerTK Phagocytosis Receptor Deficiency
por: Lew, Deborah S., et al.
Publicado: (2020)

Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
por: Carrara, Stefania C., et al.
Publicado: (2022)

Sulforaphane rescues amyloid-β peptide-mediated decrease in MerTK expression through its anti-inflammatory effect in human THP-1 macrophages
por: Jhang, Kyoung A., et al.
Publicado: (2018)

An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients
por: Lee, Ji Yun, et al.
Publicado: (2017)

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia
por: Brandao, L N, et al.
Publicado: (2013)

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
por: Myers, Kayla V., et al.
Publicado: (2019)

Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer
por: Myers Chen, Kayla V., et al.
Publicado: (2023)

Gsk3β regulates the resolution of liver ischemia/reperfusion injury via MerTK
por: Zhang, Hanwen, et al.
Publicado: (2023)

Patient-derived cell models as preclinical tools for genome-directed targeted therapy
por: Lee, Ji Yun, et al.
Publicado: (2015)

Gas6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis
por: Novitskiy, Sergey V., et al.
Publicado: (2019)

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
por: Pastore, Mirella, et al.
Publicado: (2022)

Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2–Amplified Gastric Cancer Patient–Derived Cell Model()
por: Jang, Jiryeon, et al.
Publicado: (2017)

Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers
por: Grabiec, Aleksander M, et al.
Publicado: (2018)

Study of the Role of the Tyrosine Kinase Receptor MerTK in the Development of Kidney Ischemia-Reperfusion Injury in RCS Rats
por: Pelé, Thomas, et al.
Publicado: (2021)

Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment
por: Wang, Kai-Hung, et al.
Publicado: (2020)

Gastrointestinal malignancies harbor actionable MET exon 14 deletions
por: Lee, Jeeyun, et al.
Publicado: (2015)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition
por: Xue, Gongda, et al.
Publicado: (2017)

Tyrosine Kinase Receptors Axl and MerTK Mediate the Beneficial Effect of Electroacupuncture in a Cuprizone-Induced Demyelinating Model
por: Zou, Zaofeng, et al.
Publicado: (2020)

MerTK Expression and ERK Activation Are Essential for the Functional Maturation of Osteopontin‐Producing Reparative Macrophages After Myocardial Infarction
por: Shirakawa, Kohsuke, et al.
Publicado: (2020)

The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer
por: Lee, Ji Yun, et al.
Publicado: (2015)

Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC
por: Giroud, Paul, et al.
Publicado: (2020)

Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy
por: Kim, Seung Tae, et al.
Publicado: (2017)

Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer
por: Hong, Jung Yong, et al.
Publicado: (2020)

Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial
por: Lim, Sung Won, et al.
Publicado: (2018)

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors
por: Kim, Hana, et al.
Publicado: (2021)

Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center’s experiences
por: Cho, Minho, et al.
Publicado: (2017)

Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients
por: Mohd Idrus, Fatin Najiah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sfr5aafe29il65vgq9erk0mks7